Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A New Standard of Care for Advanced Lung Cancer.

Literature DB >> 29847766

A New Standard of Care for Advanced Lung Cancer.

Joan H Schiller¹.

Abstract

Entities: Disease

Mesh：

Year: 2018 PMID： 29847766 DOI： 10.1056/NEJMe1804364

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

Review 1. Recent Trends in Potential Therapeutic Applications of the Dietary Flavonoid Didymin.

Authors: Qing Yao; Meng-Ting Lin; Yin-Di Zhu; He-Lin Xu; Ying-Zheng Zhao
Journal: Molecules Date: 2018-10-06 Impact factor: 4.411

2. Comprehensive analysis of the expression and prognosis for RBR E3 ubiquitin ligases in lung adenocarcinoma.

Authors: Hao Ding; Yuxin Wang; Yuan Cui; Zhike Chen; Yu Li; Jian Yang; Yang Yang; Tengfei Chen; Dian Xia; Chang Li; Chun Xu; Cheng Ding; Jun Zhao
Journal: Thorac Cancer Date: 2022-07-12 Impact factor: 3.223

3. The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer.

Authors: Jian Lei; Xiaoliu Liu; Wei Liu; Yun Zhang; Zhihong Liu
Journal: Ann Transl Med Date: 2021-06

4. GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration.

Authors: Zhouyangfan Peng; Pengfei Wang; Wei Song; Qingmei Yao; Yinjia Li; Linglong Liu; Yapei Li; Sufang Zhou
Journal: Signal Transduct Target Ther Date: 2020-08-24

A New Standard of Care for Advanced Lung Cancer.

Review 1. Recent Trends in Potential Therapeutic Applications of the Dietary Flavonoid Didymin.

2. Comprehensive analysis of the expression and prognosis for RBR E3 ubiquitin ligases in lung adenocarcinoma.

3. The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer.

4. GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration.

Review 5. CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC).

Review 6. Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer.

7. Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance.